A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

9.6K views

⸱

DOI:

10.3791/57646

⸱

November 11th, 2018

 ,  ,  ,  ,  ,  ,  ,  , 

In This Article

Summary

Here we describe a protocol to investigate the prenylation and guanosine-5'-triphosphate (GTP)-loading of Rho GTPase. This protocol consists of two detailed methods, namely membrane fractionation and a GTPase-linked immunosorbent assay. The protocol can be used for measuring the prenylation and GTP loading of different other small GTPases.

Abstract

The Rho GTPase family belongs to the Ras superfamily and includes approximately 20 members in humans. Rho GTPases are important in the regulation of diverse cellular functions, including cytoskeletal dynamics, cell motility, cell polarity, axonal guidance, vesicular trafficking, and cell cycle control. Changes in Rho GTPase signaling play an essential regulatory role in many pathological conditions, such as cancer, central nervous system diseases, and immune system-dependent diseases. The posttranslational modification of Rho GTPases (i.e., prenylation by mevalonate pathway intermediates) and GTP binding are key factors which affect the activation of this protein. In this paper, two essential and simple methods are provided to detect a broad range of Rho GTPase prenylation and GTP binding activities. Details of the technical procedures that have been used are explained step by step in this manuscript.

Introduction

Rho GTPases are a group of small proteins (21 - 25 kDa), which are well conserved throughout evolution, and form a unique subfamily in the Ras superfamily of small GTPases. In each subfamily within this superfamily, there is a shared G domain core that is involved in the GTPase activity and nucleotide exchange1. The difference between the Rho family and the other Ras subfamilies is the presence of a "Rho insert domain" within the 5th β strand and the 4th α helix in the small GTPase domain2.

Based on the recent classification, Rho GTPases are considered a....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Determination of RhoA Localization Using Membrane/Cytosol Fractionation

  1. Cell culture and simvastatin treatment
    1. Seed 50,000 of U251 cells in a 100 mm dish and culture them in Dulbecco's modified Eagle's medium (DMEM) (high glucose, 10% fetal bovine serum [FBS]).
    2. When 30% confluent, treat the cells by removing the medium and adding simvastatin-containing medium to it (10 µM of simvastatin dissolved in dimethyl sulfoxide [DMSO]), and incubate for 36 h at 37 °C8. Use DMSO alone as a vehicle control.
      NOTE: 10 million cells are needed for the cytosol and membrane fractio....

Access restricted. Please log in or start a trial to view this content.

Results

Membrane Fractionation:

Ultracentrifugation was used for the fractionation of membrane and cytosol components. As shown in Figure 1, the supernatant contains the cytosolic fraction and the pellet contains the membrane fraction. The abundance of RhoA in cytosolic andmembrane fractions obtained from U251 cells was examined after the treatment with simvastatin using immunoblotting. The.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Here we describe an accurate method to measure small GTPase prenylation and GTP binding shown as small GTPase subcellular localization (membrane versus cytosol) and Rho GTP loading. Small GTPases are expressed in eukaryotic cells and play essential roles in cellular proliferation, motility, and structure. Both prenylation and GTP binding are involved in the regulation of GTPase activity; therefore, assays to evaluate the prenylation and GTP binding of these proteins are important tools for cell biologists

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

Saeid Ghavami was supported by a Health Science Centre Operating Grant, CHRIM operating grant and Research Manitoba New Investigator Operating Grant. Javad Alizadeh was supported by Research Manitoba studentship. Shahla Shojaei was supported by a Health Science Foundation Operating grant and the MITACS Accelerate postdoctoral fellowship. Adel Rezaei Moghadam was supported by an NSERC operating grant which was held by Joseph W. Gordon. Amir A. Zeki was supported by the NIH/NHLBI K08 award (1K08HL114882-01A1). Marek J. Los kindly acknowledges the support from LE STUDIUM Institute for Advanced Studies (region Centre-Val de Loire, France) through its Smart Loire Valley Ge....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
DMEM high GlucoseVWR (Canada)VWRL0101-0500
Fetal Bovine SerumVWR (Canada)CA45001-106
Penicillin/StreptomycinVWR (Canada)97062-806
EDTA (Ethylenediamine tetraacetic acid)VWR (Canada)CA71007-118
EGTA (Ethylene glycol bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid)VWR (Canada)CAAAJ60767-AE
DTT (DL-Dithiothreitol)VWR (Canada)CA97061-340
Ammonium PersulfateVWR (Canada)CABDH9214-500G
Tris-HydroxymethylaminomethaneVWR (Canada)CA71009-186
30% Acrylamide/Bis SolutionBiorad (Canada)1610158
TEMEDBiorad (Canada)1610801
Protease Inhibitor cocktailSigma/Aldrich (Canada)P8340-5ML1:75 dilution
Rho-GTPase Antibody Sampler KitCell Signaling (Canada)99681:1000 dilution
Pan-Cadherin antibodyCell Signaling (Canada)40681:1000 dilution
GAPDH antibodySanta Cruz Biotechnology (USA)sc-697781:3000 dilution
RhoA G-LISA Activation Assay (Luminescence format)Cytoskeleton Inc. (USA)BK121Cytoskeleton I. G-LISA Activation Assays Technical Guide. 2016.
RhoA AntibodyCell Signaling2117
ECLAmersham-Pharmacia BiotechRPN2209
Anti-Rabbit IgG (whole molecule) Peroxidase antibodySigmaA6154-1ML
SpectraMax iD5 Multi-Mode Microplate ReaderMolecular Devices 1612071ASpectrophotometer
Nonidet P-40Sigma11332473001non-denaturing detergent, octylphenoxypolyethoxyethanol
DMSOSigmaD8418-50ML
PBSSigmaP5493-1L
Phophatase Inhibitor cocktailSigmaP5726-5ML1:75 Dilution

References

  1. Yeganeh, B., et al. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease. Pharmacology & Therapeutics. 143 (1), 87-110 (2014).
  2. Valencia, A., Chardin, P., Wittinghofer, A., Sander, C.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Rho GTPasePrenylation DetectionGTP Binding AssaySubcellular FractionationWestern Blot AnalysisUltracentrifugationSimvastatin TreatmentGlioblastoma Cell LinesProtein Localization